Zevra Therapeutics Statistics
Total Valuation
ZVRA has a market cap or net worth of $512.31 million. The enterprise value is $368.76 million.
Important Dates
The last earnings date was Wednesday, November 5, 2025, after market close.
| Earnings Date | Nov 5, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
ZVRA has 56.30 million shares outstanding. The number of shares has increased by 31.47% in one year.
| Current Share Class | 56.30M |
| Shares Outstanding | 56.30M |
| Shares Change (YoY) | +31.47% |
| Shares Change (QoQ) | -0.66% |
| Owned by Insiders (%) | 0.86% |
| Owned by Institutions (%) | 50.81% |
| Float | 47.02M |
Valuation Ratios
The trailing PE ratio is 16.93 and the forward PE ratio is 22.90.
| PE Ratio | 16.93 |
| Forward PE | 22.90 |
| PS Ratio | 5.70 |
| Forward PS | 3.49 |
| PB Ratio | 3.72 |
| P/TBV Ratio | 4.15 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | 12.29 |
| EV / Sales | 4.37 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 8.62, with a Debt / Equity ratio of 0.47.
| Current Ratio | 8.62 |
| Quick Ratio | 8.29 |
| Debt / Equity | 0.47 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -3.52 |
Financial Efficiency
Return on equity (ROE) is 34.81% and return on invested capital (ROIC) is -11.12%.
| Return on Equity (ROE) | 34.81% |
| Return on Assets (ROA) | -7.84% |
| Return on Invested Capital (ROIC) | -11.12% |
| Return on Capital Employed (ROCE) | -11.87% |
| Revenue Per Employee | $1.43M |
| Profits Per Employee | $508,746 |
| Employee Count | 59 |
| Asset Turnover | 0.37 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, ZVRA has paid $18.32 million in taxes.
| Income Tax | 18.32M |
| Effective Tax Rate | 34.15% |
Stock Price Statistics
The stock price has increased by +1.11% in the last 52 weeks. The beta is 1.00, so ZVRA's price volatility has been similar to the market average.
| Beta (5Y) | 1.00 |
| 52-Week Price Change | +1.11% |
| 50-Day Moving Average | 9.56 |
| 200-Day Moving Average | 9.00 |
| Relative Strength Index (RSI) | 39.63 |
| Average Volume (20 Days) | 1,656,031 |
Short Selling Information
The latest short interest is 7.99 million, so 14.20% of the outstanding shares have been sold short.
| Short Interest | 7.99M |
| Short Previous Month | 9.07M |
| Short % of Shares Out | 14.20% |
| Short % of Float | 17.00% |
| Short Ratio (days to cover) | 2.96 |
Income Statement
In the last 12 months, ZVRA had revenue of $84.39 million and earned $30.02 million in profits. Earnings per share was $0.54.
| Revenue | 84.39M |
| Gross Profit | 68.06M |
| Operating Income | -28.96M |
| Pretax Income | 53.64M |
| Net Income | 30.02M |
| EBITDA | -23.62M |
| EBIT | -28.96M |
| Earnings Per Share (EPS) | $0.54 |
Full Income StatementBalance Sheet
The company has $199.51 million in cash and $62.72 million in debt, giving a net cash position of $136.79 million or $2.43 per share.
| Cash & Cash Equivalents | 199.51M |
| Total Debt | 62.72M |
| Net Cash | 136.79M |
| Net Cash Per Share | $2.43 |
| Equity (Book Value) | 133.17M |
| Book Value Per Share | 2.37 |
| Working Capital | 199.00M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$23.36 million and capital expenditures -$866,000, giving a free cash flow of -$24.23 million.
| Operating Cash Flow | -23.36M |
| Capital Expenditures | -866,000 |
| Free Cash Flow | -24.23M |
| FCF Per Share | -$0.43 |
Full Cash Flow StatementMargins
Gross margin is 80.65%, with operating and profit margins of -34.32% and 41.86%.
| Gross Margin | 80.65% |
| Operating Margin | -34.32% |
| Pretax Margin | 63.57% |
| Profit Margin | 41.86% |
| EBITDA Margin | -27.99% |
| EBIT Margin | -34.32% |
| FCF Margin | n/a |
Dividends & Yields
ZVRA does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -31.47% |
| Shareholder Yield | -31.47% |
| Earnings Yield | 5.94% |
| FCF Yield | -4.79% |
Analyst Forecast
The average price target for ZVRA is $21.71, which is 138.57% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $21.71 |
| Price Target Difference | 138.57% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 7 |
| Revenue Growth Forecast (5Y) | 76.37% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside | |
Stock Splits
The last stock split was on December 28, 2020. It was a reverse split with a ratio of 1:16.
| Last Split Date | Dec 28, 2020 |
| Split Type | Reverse |
| Split Ratio | 1:16 |
Scores
ZVRA has an Altman Z-Score of 0.65 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 0.65 |
| Piotroski F-Score | 4 |
